Search Results - "Praestgaard, Amy"

A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'".

Authors: Ständer, Sonja Pinter, Andreas Hougeir, Firas G. et al.

Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p1433-1437. 5p.

Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.

Authors: Ständer, Sonja Yosipovitch, Gil Kwatra, Shawn G. et al.

Source: Dermatology & Therapy. Jun2026, Vol. 16 Issue 6, p3189-3200. 12p.

Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis.

Authors: Ständer, Sonja Yosipovitch, Gil Kim, Brian S. et al.

Source: Dermatology & Therapy. Nov2025, Vol. 15 Issue 11, p3437-3446. 10p.

Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison.

Authors: Ständer, Sonja Pinter, Andreas Hougeir, Firas G. et al.

Source: Dermatology & Therapy. Sep2025, Vol. 15 Issue 9, p2537-2551. 15p.

Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data.

Authors: Rehberg, Markus Giegerich, Clemens Praestgaard, Amy et al.

Source: Rheumatology & Therapy. Dec2021, Vol. 8 Issue 4, p1921-1922. 2p.

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison.

Authors: Huizinga, Thomas Choy, Ernest Praestgaard, Amy et al.

Source: Rheumatology & Therapy. Jun2023, Vol. 10 Issue 3, p539-550. 12p.

Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial.

Authors: Fokkens, Wytske J Bachert, Claus Hopkins, Claire et al.

Source: Clinical & Translational Immunology. 2024, Vol. 13 Issue 6, p1-8. 8p.

Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry.

Authors: Curtis, Jeffrey R. Yun, Huifeng Chen, Lang et al.

Source: Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p217-217. 1p.

Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data.

Authors: Rehberg, Markus Giegerich, Clemens Praestgaard, Amy et al.

Source: Rheumatology & Therapy. Dec2021, Vol. 8 Issue 4, p1661-1675. 15p.

Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52.

Authors: Bachert, Claus Khan, Asif H. Lee, Stella E. et al.

Source: International Forum of Allergy & Rhinology. Mar2024, Vol. 14 Issue 3, p668-678. 11p.

Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle study.

Authors: Husain-Syed, Faeq DiFrancesco, Matthew F Deo, Rajat et al.

Source: Clinical Kidney Journal. Sep2023, Vol. 16 Issue 9, p1508-1520. 13p.

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry.

Authors: Curtis, Jeffrey R. Yun, Huifeng Chen, Lang et al.

Source: Rheumatology & Therapy. Aug2023, Vol. 10 Issue 4, p1055-1072. 18p.

Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey).

Authors: Paller, Amy S. Weidinger, Stephan Capozza, Korey et al.

Source: Dermatology & Therapy. Apr2023, Vol. 13 Issue 4, p961-980. 20p.

Abstracts from 13th Georg Rajka International Symposium on Atopic Dermatitis, Gdańsk, Poland August 31–September 2, 2023.

Source: Acta Dermato-Venereologica. 2023, Vol. 103, p1-64. 64p.

Author Index.

Source: Pediatric dermatology May2023 Supplement 1; Vol. 40.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0736-8046

Author Index.

Source: Pediatric dermatology Mar2023 Supplement 1; Vol. 40.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0736-8046

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps.

Authors: Hellings, Peter W. Peters, Anju T. Chaker, Adam M. et al.

Source: International Forum of Allergy & Rhinology. Jul2022, Vol. 12 Issue 7, p958-962. 5p.

ABSTRACTS from 12^th Georg Rajka International Symposium on Atopic Dermatitis.

Source: Acta Dermato-Venereologica. 2022 Supplement, Vol. 102, p1-65. 67p.

ISPE20 Author Index.

Source: Pharmacoepidemiology and drug safety Sep2022 Supplement S1; Vol. 31.

Journal Info: Publisher: Wiley-Blackwell ISSN: 1053-8569

AUTHOR INDEX.

Source: Pediatric dermatology May2022 Supplement S1; Vol. 39.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0736-8046